Table 4.
Results of amplicon scheme sequencing on five Zika-positive clinical samples from Columbia using the ZikaAsian scheme on the Illumina MiSeq.
| Sampl e | Ct 1 | GE/ul RNA 2 | Reads | ZIKV reads 3 | % ZIKV | % Coverage | Depth | Genbank ID |
|---|---|---|---|---|---|---|---|---|
| ZC188 | 34 | 36 | 1,114,568 | 760,976 | 68.3 | 98.3 | 29,395 | KY317936 |
| ZC192 | 33.9 | 39 | 1,246,644 | 795,474 | 63.8 | 98.4 | 30,396 | KY317937 |
| ZC199 | 35.9 | 10 | 2,772,457 | 379,064 | 13.7 | 93.4 | 14,848 | KY317938 |
| ZC204 | 33.6 | 48 | 1,065,517 | 751,872 | 70.6 | 99.7 | 29,003 | KY317939 |
| ZC207 | 35.2 | 16 | 939,820 | 506,821 | 53.9 | 96.7 | 19,478 | KY317940 |
qRT-PCR cycle threshold (Ct) value
Genome copy equivalents (GE) per microlitre calculated from Ct value and standard dilutions.
Number of reads aligning to a Zika virus reference genome